Dr. Amber Nagy

Dr. Amber Nagy serves as a key procurement lead at the Naval Medical Research Center, supporting the Department of the Navy’s mission to enhance force health protection through advanced biomedical innovation. She manages complex acquisitions for laboratory-grade diagnostic systems, field-deployable analytical instruments, and specialized electronic components critical to infectious disease surveillance and operational readiness in austere environments. Her work directly enables the development and validation of next-generation medical technologies used by Navy and Marine Corps personnel worldwide, ensuring rapid, reliable, and ruggedized solutions for frontline medical teams. Dr. Nagy maintains a primary contracting relationship with REES SCIENTIFIC CORPORATION, a trusted vendor specializing in precision analytical instrumentation and custom diagnostic hardware. Her procurement pattern reflects a sustained, long-term partnership with this contractor, characterized by iterative development cycles, technical collaboration, and delivery of mission-critical systems requiring stringent military specifications. While REES SCIENTIFIC CORPORATION is the dominant vendor, her portfolio also includes other qualified suppliers capable of meeting high-performance standards for laboratory and field-use medical electronics. Dr. Nagy’s contracting activity is exclusively non-set-aside, with 100% of awards issued under full and open competition. This reflects a deliberate focus on technical capability and performance over socioeconomic preferences, prioritizing mission-critical outcomes and the availability of specialized engineering expertise required for defense-grade medical systems. While small business participation is not formally incentivized in her portfolio, all vendors must meet rigorous qualification standards for defense logistics and quality assurance. Her procurement focus centers on NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 334419 (Other Electronic Component Manufacturing), encompassing PCR-based pathogen detection systems, portable mass spectrometers, biosensor arrays, and embedded medical electronics. She specializes in acquiring ruggedized, lab-to-field transition technologies that meet MIL-STD and FDA-cleared standards, demonstrating deep expertise in biomedical instrumentation, diagnostic algorithm integration, and environmental resilience requirements for military operations.